Recombinant Shigella boydii serotype 4 Protein CrcB homolog (crcB) is a protein expressed by the crcB gene in Shigella boydii serotype 4 . Shigella boydii is a species of bacteria that causes shigellosis, an infectious disease also known as bacillary dysentery, which leads to diarrhea .
Shigella boydii is one of the serotypes of Shigella bacteria prevalent in areas like Bangladesh . The World Health Organization (WHO) recognizes Shigella as a priority for research and development of new drugs because of its impact on public health .
Studies on Shigella often involve identifying and characterizing its various serotypes, because immunity to Shigella is serotype-specific . One study isolated a novel phage, MK-13, which specifically lyses S. boydii type 1 but does not lyse other serotypes of Shigella or other enteric bacteria tested . The study also showed the prevalence of 20 different serotypes of S. boydii in Bangladesh and diagnosis of S. boydii serotypes without using antisera .
KEGG: sbo:SBO_0489
Based on established protocols for the recombinant protein :
| Storage Parameter | Recommended Condition | Notes |
|---|---|---|
| Short-term storage | 4°C | Viable for up to one week |
| Long-term storage | -20°C | Standard storage condition |
| Extended storage | -80°C | For maximum stability |
| Buffer composition | Tris-based buffer with 50% glycerol | Optimized for this specific protein |
| Freeze-thaw cycles | Minimize | Repeated freezing and thawing is not recommended |
Methodological considerations:
Always use sterile technique when handling protein aliquots
Prepare working aliquots to avoid repeated freeze-thaw cycles
When thawing, place on ice and use immediately for experiments
For experimental use, dilute in appropriate buffers immediately before use
Check protein activity periodically if stored for extended periods
Production and purification of the recombinant CrcB homolog typically follows these methodological steps:
Expression System Selection:
E. coli BL21(DE3) or similar expression strains are commonly used
Selection of appropriate expression vector with affinity tag (typically His-tag as indicated in product specifications )
Temperature optimization during induction phase (typically 16-30°C)
Expression Protocol:
Transform expression vector containing the crcB gene into competent E. coli cells
Culture in appropriate media (LB or similar) with selective antibiotics
Induce protein expression at optimal OD600 (typically 0.6-0.8) using IPTG
Continue expression for determined time period (3-16 hours depending on protein stability)
Purification Strategy:
Cell lysis using mechanical disruption or detergent-based methods
Immobilized metal affinity chromatography (IMAC) using Ni-NTA resin
On-column refolding if necessary
Elution with imidazole gradient
Dialysis into storage buffer (Tris-based with 50% glycerol as per specifications )
Quality control by SDS-PAGE and western blotting
Similar approaches have been successfully employed for other Shigella proteins, such as the α domain of VirG , which was expressed in E. coli with yields of 6.2 mg/L culture, >95% purity, and <1% residual host-cell proteins.
The crcB gene in S. boydii serotype 4 is designated by the ordered locus name SBO_0489 . Comparative genomic analysis reveals interesting patterns:
Genomic analysis of S. boydii has revealed that the species consists of three distinct phylogenetic clades, with clade 1 being the most divergent and containing 98 unique genes compared to only 4 and 12 unique genes in clades 2 and 3, respectively . The genetic diversity within S. boydii is particularly significant given that the average genome size is approximately 4,397,328 bp with a GC content of around 50.75% .
Methodological approach for comparative genomic analysis:
Whole genome sequencing using next-generation sequencing platforms
Alignment using tools like Mugsy algorithm for reference-independent comparison
Phylogenomic analysis using RAxML or similar tools
Protein coding gene comparison using large-scale BLAST score ratio (LS-BSR) analysis
As a putative ion channel, several specialized methodologies can be employed to characterize the functional properties of the CrcB homolog:
1. Electrophysiological Methods:
Planar lipid bilayer recordings to measure single-channel conductance
Patch-clamp analysis of cells expressing recombinant CrcB
Ion flux measurements using fluorescent probes (e.g., PBFI for fluoride)
2. Fluoride Sensitivity Assays:
Growth inhibition assays with varying fluoride concentrations
Complementation studies in crcB knockout strains
Fluoride uptake assays using radioactive 18F or fluoride-sensitive probes
3. Structural Analysis:
Cryo-electron microscopy to determine membrane protein structure
X-ray crystallography (though challenging for membrane proteins)
NMR spectroscopy for dynamic structural information
4. Computational Approaches:
Molecular dynamics simulations to model ion conductance
Homology modeling based on related ion channel structures
In silico docking to identify potential inhibitors or modulators
5. Mutagenesis Studies:
Alanine scanning mutagenesis to identify key residues
Cysteine accessibility methods to map the pore structure
Chimeric constructs with other CrcB homologs to determine domain functions
These approaches can be combined with bacterial viability and pathogenicity assays to link channel function with bacterial survival under various conditions, similar to strategies used in studying other Shigella membrane proteins.
While CrcB homolog itself has not been specifically identified as a vaccine candidate in the literature, research approaches using recombinant Shigella proteins provide a framework for such investigations:
Antigen Potential Assessment:
Epitope mapping of CrcB to identify potential B-cell and T-cell epitopes
Surface accessibility analysis (CrcB is a membrane protein with potentially accessible extracellular domains)
Conservation analysis across Shigella serotypes and strains
Immunogenicity Studies:
Evaluation of immune responses in animal models using purified recombinant CrcB
Analysis of antibody titers using ELISA
Assessment of cellular immune responses via ELISpot or flow cytometry
Vaccine Formulation Approaches:
Subunit vaccine approach using purified CrcB or epitope-derived peptides
Adjuvant selection for optimal immune response
Delivery systems (e.g., liposomes, virus-like particles)
Lessons from successful Shigella vaccine research, such as work with the VirG protein, can inform CrcB studies. For example, VirG α domain (VirGα) has shown promise as a cross-protective vaccine candidate against multiple Shigella serotypes . When administered intramuscularly with alum, VirGα elicited robust immune responses and high protective efficacy against both S. flexneri 2a and S. sonnei. Almost complete protection was achieved when VirGα was given intranasally with E. coli double mutant heat-labile toxin (dmLT) .
| Approach | Advantages | Challenges |
|---|---|---|
| Surface-exposed epitopes | Direct antibody accessibility | Limited exposure of membrane proteins |
| Conserved epitopes | Cross-protection potential | Potentially less immunogenic |
| Combination with other antigens | Broader protection | Potential antigenic competition |
| Live attenuated vectors expressing CrcB | Strong cellular immunity | Safety concerns |
While specific information about the role of CrcB in S. boydii pathogenesis is limited, we can analyze its potential functions based on current understanding of Shigella pathogenesis and related bacterial systems:
Potential Roles in Pathogenesis:
Methodological Approaches to Study These Roles:
Gene Knockout Studies:
Transcriptional Analysis:
Quantify crcB expression during infection using RT-qPCR
RNA-seq to identify co-regulated genes under stress conditions
In Vivo Infection Models:
Compare wild-type and crcB mutant strains in animal models
Assess colonization, persistence, and pathological outcomes
Cell Culture Assays:
Invasion assays using epithelial cell lines
Survival within macrophages
For context, other Shigella proteins like VirG (IcsA) are known to be essential for bacterial pathogenesis. VirG mediates actin-based motility and IcsB prevents autophagy, allowing Shigella to spread efficiently within host tissues . Understanding whether and how CrcB contributes to these processes would be valuable.
Bioinformatic analyses can provide valuable insights into potential functional interactions of the CrcB homolog:
Protein-Protein Interaction Prediction:
Sequence-based methods (co-evolution analysis, domain-domain interaction predictions)
Structure-based approaches (docking simulations, interface predictions)
Network-based methods (functional association networks, gene neighborhood analysis)
Comparative Genomic Approaches:
Phylogenetic profiling to identify co-occurring genes across genomes
Synteny analysis to identify conserved gene neighborhoods
Operon prediction to identify potentially co-regulated genes
Functional Annotation Transfer:
Ortholog identification and functional annotation transfer
Domain-based function prediction
Gene Ontology (GO) term enrichment analysis
Implementation Strategy:
| Analysis Step | Tools | Expected Outputs |
|---|---|---|
| Homology detection | BLAST, HHpred, HMMER | Identification of related proteins with known functions |
| Structural modeling | AlphaFold2, I-TASSER, Phyre2 | 3D structure predictions |
| Functional domain analysis | InterProScan, Pfam, SMART | Identification of functional domains and motifs |
| Protein-protein interaction | STRING, IntAct, STITCH | Prediction of interaction partners |
| Genomic context analysis | MicrobesOnline, SyntTax, FgenesB | Identification of genomic neighborhoods |
| Evolutionary analysis | MEGA, PhyML, MrBayes | Phylogenetic relationships with other CrcB proteins |
These bioinformatic approaches can guide experimental design by generating testable hypotheses about CrcB function in S. boydii. For example, if genomic context analysis reveals co-localization with stress response genes, this would suggest a role in stress adaptation that could be experimentally validated.
The genomic diversity observed within S. boydii (consisting of three major clades with different gene content) highlights the importance of comparative genomic approaches for understanding the function and evolution of proteins like CrcB.
Membrane proteins like CrcB present unique challenges in recombinant expression and purification:
Common Challenges and Solutions:
Low Expression Levels:
Optimization of codon usage for expression host
Use of specialized expression vectors with strong but controllable promoters
Testing multiple expression hosts (E. coli C41/C43, Pichia pastoris, insect cells)
Fusion tags to enhance expression (MBP, SUMO, Mistic)
Protein Misfolding and Aggregation:
Expression at lower temperatures (16-25°C)
Co-expression with chaperones (GroEL/ES, DnaK/J)
Addition of chemical chaperones to growth media
Optimization of induction conditions (IPTG concentration, OD at induction)
Toxicity to Host Cells:
Use of tightly regulated inducible systems
Leak-free expression systems (T7 lysozyme co-expression)
Cell-free expression systems
Solubilization and Purification:
Screening different detergents (DDM, LDAO, Fos-choline)
Use of styrene maleic acid lipid particles (SMALPs)
Nanodisc technology for maintaining native-like lipid environment
Optimization of purification buffers and conditions
Experimental Design Framework:
| Stage | Optimization Strategy | Analytical Methods |
|---|---|---|
| Expression | Test multiple hosts, vectors, and conditions | SDS-PAGE, Western blot, GFP fusion tracking |
| Membrane extraction | Detergent screening, gentle lysis methods | Light scattering, protein quantification |
| Purification | IMAC, size exclusion, ion exchange | SDS-PAGE, Western blot, activity assays |
| Functional validation | Reconstitution into liposomes or nanodiscs | Fluoride transport assays, structural analysis |
Case Study Approach:
Recent work with membrane proteins from related bacteria can guide S. boydii CrcB expression strategies. For example, successful expression and purification of VirG protein from Shigella required optimization of E. coli expression systems, with specific attention to refolding conditions . Similar approaches could be applied to CrcB, with adaptations for its membrane protein nature.
The genetic diversity of S. boydii has significant implications for research on specific proteins:
Genetic Diversity of S. boydii:
Genome analysis has revealed that S. boydii exists in three distinct phylogenetic clades with significant genetic differences :
Clade 1 contains 98 unique genes not found in clades 2 and 3
Clades 2 and 3 have only 4 and 12 unique genes, respectively
The average S. boydii genome size is approximately 4,397,328 bp with a GC content of around 50.75%
Implications for CrcB Research:
Sequence Variation:
Potential variations in the crcB gene sequence across different S. boydii clades
Impacts on protein structure, function, and regulation
Expression Patterns:
Variations in promoter regions may affect expression levels
Differential regulation in different genetic backgrounds
Functional Relevance:
Potential adaptation to different ecological niches
Role in specific pathogenicity mechanisms
Methodological Considerations:
Sampling Strategy:
Inclusion of strains from different clades in research studies
Phylogenetic characterization of strains used in functional studies
Comparative Analysis:
Sequence alignment of crcB genes from different S. boydii strains
Functional comparison of CrcB proteins from different clades
Standardization Approaches:
Use of reference strains from each clade
Development of clade-specific primers and antibodies
The large-scale BLAST score ratio (LS-BSR) analysis approach used to compare protein-encoding genes between S. boydii genomes could be specifically applied to analyze the conservation and variation of the crcB gene across different isolates. This would provide insights into the evolutionary pressures on this gene and its functional importance across different genetic backgrounds.